Long Sun, PhD

18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT

68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT

68Ga-DOTA-hLAG-3 PET/CT

18F-FDG, 18F-AlF-FAPI PET/CT

18F-FDG PET/CT and PET/CT-guide targeted biopsy in another group of participants

68Ga-DOTA-FAPI, 177Lu-DOTA-FAPI

phase_1

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

7 unique interventions3 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed5

Other2

Role Distribution

Principal Investigator1

Other Roles6

PI Rate14%

Activity Timeline

Clinical Trials (7)

NCT05346276Completed

hLAG-3PET/CTTUMOR

StudychairStart date: 2022-10-10

NCT05543317Not ApplicableCompleted

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission TomographyTumor, Solid

StudychairStart date: 2022-07-01

NCT05430841Not ApplicableCompleted

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Gastric CancerLiver CancerPancreatic Cancer

StudychairStart date: 2022-06-01

NCT05392205Not ApplicableCompleted

Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer

Positron-Emission TomographyTumor, Solid

StudydirectorStart date: 2022-03-01

NCT04941872Not ApplicableCompleted

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

Tumor, Solid, FAPI, PET/CT, Metastasis

StudydirectorStart date: 2021-06-18

NCT04849247Phase 1Unknown

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI68Ga-DOTA-FAPITheranostic

StudychairStart date: 2021-04-13

NCT04553601Not ApplicableUnknown

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

BiopsyGenomicsNSCLC+3 more

PrincipalinvestigatorStart date: 2019-10-01

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

PET/CT2 Positron-Emission Tomography2 Tumor, Solid2 177Lu-DOTA-FAPI1 68Ga-DOTA-FAPI1 Biopsy1 Cancer of Stomach1 Genomics1

Affiliations

The First Affiliated Hospital of Xiamen University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

NeoplasmsCancer of LiverCancer of Pancreas

Similarity Score5%

Ajay Goel, PhD

City of Hope Medical Center

24 trials

Shared therapeutic areas:

Cancer of StomachCancer of LiverCancer of Pancreas

Similarity Score5%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Cancer of LiverCancer of PancreasCancer of Stomach

Similarity Score5%

Lizhi Niu, PhD

Fuda Cancer Hospital

31 trials

Shared therapeutic areas:

Cancer of LiverCancer of Pancreas

Cancer of LiverCancer of Pancreas

Jeong Min Lee, MD

Seoul National University Hospital

34 trials

Shared therapeutic areas:

Cancer of PancreasCancer of Liver

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

GenomicsWhole Exome Sequencing

Lei Li, M.D.

Peking Union Medical College Hospital

46 trials

Shared therapeutic areas:

Cancer of StomachCancer of Pancreas

Lin Shen, MD

Peking University Cancer Hospital & Institute

20 trials

Shared therapeutic areas:

Worked with same sponsors:

The First Affiliated Hospital of Xiamen University

Cancer of PancreasCancer of Liver

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

29 trials

Shared therapeutic areas:

Alice P Chen, M.D.

National Cancer Institute (NCI)

18 trials

Shared therapeutic areas:

NeoplasmsNSCLC